Northern Trust’s Korsana Biosciences KRSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-577
Closed -$35.1K – 4545
2023
Q1
$35.1K Hold
577
– – ﹤0.01% 4345
2022
Q4
$53K Hold
577
– – ﹤0.01% 4270
2022
Q3
$69K Hold
577
– – ﹤0.01% 4229
2022
Q2
$44K Hold
577
– – ﹤0.01% 4441
2022
Q1
$90K Hold
577
– – ﹤0.01% 4380
2021
Q4
$139K Buy
577
+64
+12% +$21.2K ﹤0.01% 4320
2021
Q3
$220K Buy
513
+51
+11% +$23.4K ﹤0.01% 4133
2021
Q2
$252K Sell
462
-1,245
-73% -$546K ﹤0.01% 4054
2021
Q1
$667K Sell
1,707
-129
-7% -$67.8K ﹤0.01% 3734
2020
Q4
$787K Sell
1,836
-65
-3% -$31K ﹤0.01% 3600
2020
Q3
$1.62M Buy
1,901
+141
+8% +$113K ﹤0.01% 3154
2020
Q2
$1.46M Sell
1,760
-195
-10% -$114K ﹤0.01% 3197
2020
Q1
$725K Sell
1,955
-95
-5% -$47.4K ﹤0.01% 3343
2019
Q4
$780K Buy
2,050
+26
+1% +$17K ﹤0.01% 3465
2019
Q3
$3.43M Buy
2,024
+666
+49% +$1.01M ﹤0.01% 2774
2019
Q2
$2.18M Buy
+1,358
New +$2.69M ﹤0.01% 3045

Other funds holding KRSA

Northern Trust's KRSA Position: Q2 2023 in Review

Northern Trust sold out of Korsana Biosciences (KRSA) in Q2 2023, closing a stake of 577 shares — an estimated $35.1K sold.

Northern Trust first reported a position in KRSA in Q2 2019 and held it in 16 quarters. The position peaked at $3.43M in Q3 2019. 17 funds tracked by Wall St. Rank hold KRSA as of Q2 2023.

  • Northern Trust reported no remaining Korsana Biosciences position as of Q2 2023 after selling out during the quarter.
  • Northern Trust sold 577 Korsana Biosciences shares in Q2 2023, an estimated $35.1K.
  • Northern Trust first reported a position in Korsana Biosciences in Q2 2019 and held it in 16 quarters.
  • Northern Trust's Korsana Biosciences position peaked at $3.43M in Q3 2019.
  • 17 funds tracked by Wall St. Rank held Korsana Biosciences as of Q2 2023.

Based on Northern Trust's 13F filing for Q2 2023, filed 11 Aug 2023.